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Background
HIV/AIDS is now a major global health problem. In 2012, there were 1.6 million AIDS 
related deaths and at least 32 million adults and children were living with HIV globally. 
The situation is still far from the global vision of zero new HIV infections, zero discrimi-
nation and zero AIDS-related deaths (UNAIDS 2013). Fungal infections remain a clini-
cal challenge in HIV patients with severe immune suppression conditions. The Candida 
species contributes up to 33.1 % of fungal infections among HIV diagnosed individuals. 
Abstract 
Candida sp contributes 33.1 % of fungal infections among HIV patients. Among the 
species of the genus Candida, Candida albicans is the most frequently isolated from HIV 
patients. This study aimed to analyze putative virulence factors of C. albicans isolated 
from oral cavities of HIV infected patients and healthy individuals. Twenty isolates from 
HIV infected patients and fourteen from healthy individuals were analyzed for phe-
notypic switching, cell growth rate, hyphae formation, hemolytic activity and biofilm 
formation characteristics. The frequency of phenotypic switching was low in both 
groups. The cell growth rate of C. albicans from HIV infected patients were significantly 
higher than those from healthy individuals (p < 0.001). After 48 h incubation, the 
concentration of C. albicans isolated from HIV infected patients was 8.6 × 106 cells/ml 
while the concentration of C. albicans isolated from healthy individuals was 7.8 × 106 
cells/ml. After 72 h incubation, the concentration of C. albicans isolated from HIV 
infected patients was 9.5 × 106 cells/ml while the concentration of C. albicans isolated 
from healthy individuals was 8.2 × 106 cells/ml. In contrast, the hemolytic activity of C. 
albicans isolated from healthy individuals were significantly higher compared to those 
from HIV infected patients (p < 0.001) at both aerobic (6 vs. 3.5 mm) and anaerobic (3.8 
vs. 1.3 mm) conditions. The percentages of hyphae forming cells were higher in C. albi-
cans collected from HIV infected patients (27.5 %) compared to the healthy individual 
group (14.7 %). However, this trend was not statistically significant (p = 0.1). Candida 
albicans isolated from HIV infected patients have similar ability to develop biofilms 
compared to those from healthy individuals. (OR = 4.2; 95 % CI 0.724–26.559). The 
virulence factors of C. albicans isolated from HIV infected patients were not significantly 
different from those of healthy individuals. The results add new insights into the con-
tribution of virulence factors in the pathogenesis of C. albicans infection in HIV infected 
patients.
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CD4+ cell counts <200 cells/μl and other underlying conditions in HIV patients were 
found susceptible to invasive candidiasis (Marukutira et al. 2014) with C. albicans being 
the most frequently isolated (Fidel 2011; Anwar et al. 2012; Okonkwo et al. 2012).
The Candida species are endogenous microbes in several organ systems, including 
the mouth and the intestines. While these fungi are commonly considered to be non 
pathogenic, they are responsible for opportunistic infections. Candida may alter from 
the commensally harmless to a pathogenic state. This may occur following alteration of 
the oral cavity environment thus favoring its growth (Williams and Lewis 2011). There 
are several clinical presentations related with C. albicans infection in the oral cavity of 
HIV patients; i.e. xerostomia, oral hairy leukoplakia, necrotizing ulcerative periodonti-
tis, Kaposi’s sarcoma, human papilloma virus-associated warts, and other ulcers (Reznik 
2006).
Several putative virulence factors of C. albicans have been reported such as pheno-
typic switching, hyphae formation, biofilm formation, esterase production, phospholi-
pase expression, proteinase production, hemolytic activity, adhesin activity and invasin 
(Mayer et al. 2013). However, only few of these putative virulence factors were studied in 
HIV infected patients. Interestingly, all C. albicans isolates from HIV infected patients 
were shown to produce intermediate to high levels of proteinase and phospholipase 
(Menezes et al. 2013). Biofilm formation was reported to be similar between C. albicans 
isolates from HIV infected patients and healthy individuals (Jin et al. 2003) and the phe-
notypic switching of C. albicans was considered high in HIV infected patients (Vargas 
et al. 2000). It is thus important to study the pathogenesis of C. albicans in HIV infected 
patients. The immune response which is compromised in HIV infected patients or viru-
lence factors of C. albicans which is working as underlying mechanism, are interesting 
subjects to be elucidated.
This study aimed to analyze some putative virulence factors of C. albicans isolated 
from the oral cavity of HIV infected patients and healthy individuals. Our results showed 
that some of the virulence factors are significantly different among those two series of C. 
albicans. This result may add new insights to the contribution of virulence factors in the 
pathogenesis of C. albicans infection in HIV infected patients.
Methods
C. albicans isolates
This study made use of archived C. albicans isolates. A total of thirty-four (34) C. albi-
cans isolates were obtained. Twenty (20) isolates were from HIV infected patients and 
fourteen (14) isolates came from healthy individuals. Candida albicans was cultured 
from rinsed oral cavity fluids of HIV infected patients and healthy individuals. Candida 
albicans identification was performed using chromogenic CHROMagar™ Candida. The 
C. albicans isolates were subsequently cryo-preserved at −80 °C until further analysis.
A unique code was assigned for every isolate to protect the identities of the patients 
and the healthy volunteers. The protocol received approval from the Medical and Health 
Research Ethics Committee of the Faculty of Medicine, Universitas Gadjah Mada, Yog-
yakarta, Indonesia.
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Phenotyphic switching induction
Frozen C. albicans isolates were thawed and inoculated on yeast extract peptone dex-
trose (YPD) solid medium and incubated for 3 days at 25 °C. A colony from each isolate 
was taken from the YPD medium, again inoculated on YPD, and incubated for 3 days at 
25 °C. One to five single colonies were diluted with 200 μl sterile water, and adjusted to 
McFarland 0.5 standard to get 1 ×  106 CFU/ml concentrations. The yeast suspension 
was inoculated on YPD medium supplemented with 50 μg/ml phloxin B, and incubated 
for 3 days at 25 °C. The opaque cells produced red colonies and the white cells were reg-
ular white colonies. Cell morphology was confirmed using a light microscope after lacto 
phenol cotton blue staining. The opaque cells appeared dark and oval while the white 
cells appeared bright and spherical. To define the frequency of phenotypic switching, 
each isolate was cultured on YPD medium supplemented with phloxin B. This was done 
for at least 4,000 colonies (Hnisz et al. 2011).
Cell growth rate
Candida albicans was grown on Saboroud’s Dextrose Agar (SDA) supplemented with 
5 % chloramphenicol. Several colonies of C. albicans were inoculated into casein-yeast-
glucose (CYG) broth. The cell concentration was measured using a spectrophotometer at 
540 nm. Initial concentrations of all C. albicans isolates were calibrated into equal opti-
cal density (OD), and considered as zero minute concentrations. The yeast suspensions 
were then incubated at room temperature. Cell concentrations were measured serially at 
0, 12, 24, 48, and 72 h after inoculation. The growth curves of yeast were obtained from 
duplicate measurements using a spectrophotometer. The conversion of OD to cell con-
centration was performed according to the formula published by Rodrigues et al. (1993)
Hyphae formation
Candida albicans was inoculated into fetal bovine serum (FBS) and incubated for 
90 min at 37  °C. After incubation, the cells were counted using a hemocytometer cell 
counter (Rodrigues et al. 1993). The total number of cells and hyphae forming cells were 
determined and the percentages of hyphae forming cells were calculated. Duplicate 
independent cell counting was done.
Hemolytic activity
Yeast suspension was prepared from several colonies of C. albicans and was adjusted to 
McFarland 0.5. Ten (10) μl of yeast suspension was dropped on SDA supplemented with 
5 % chloramphenicol, 7 % sheep blood and 3 % glucose, and incubated at 37 °C for 48 h 
in both aerobic and anaerobic condition as described by Inci et al. (2012). After incuba-
tion, the transparent zone around the colonies was considered the hemolytic zone. The 
diameter of both hemolytic zones and the colonies were then measured. The hemolytic 
zone diameter was subtracted from the diameter of the colonies and was documented as 
the hemolytic activity level in this study. Triplicate independent experiments were done.
Cell concentration = {64.3 + (8.206×OD)} × 103cells/ml.
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Biofilm formation
Candida albicans was inoculated into YPD broth and incubated for 24  h at 37  °C. 
Then, the yeast suspension was washed and centrifuged three times at 3,000  rpm for 
10 min. The pellet was diluted with RPMI 1640 and the cell concentration was adjusted 
to 106  CFU/ml. The suspension was transferred into 96 wells polystyrene microplates 
with as much as 200 μl for each well. This was then incubated for 48 h at room tem-
perature. Each C. albicans isolate was cultured into eight wells to have eight replication 
results. The wells were washed twice with 10 mM PBS. After washing, 50 μl 1 % crystal 
violet was added into the wells and kept at room temperature for 30  min. Water was 
used to rinse the wells for three times. Finally, 200 μl acidic isopropanol was added into 
the wells and kept at room temperature for 10 min. The ODs were measured using the 
ELISA reader at 595 nm (Thermo Scientific). The cut-off point of the biofilm forming 
C. albicans was calculated using the formula: 3 × StDev + OD of control. The control 
is considered as the well that was added with broth medium without C. albicans. The 
C. albicans with OD less than the cut-off was considered as non adhered (non biofilm 
forming); less than 2 times of the cut-off was considered as weakly adhered; 2–4 times of 
the cut-off was considered as moderately adhered; and more than 4 times the cut-off was 
considered as strongly adhered (Stepanovic et  al. 2004). The data of each isolate were 
obtained from 8 replicate wells of duplicate independent experiments. Only 12 out of 14 
C. albicans isolated from healthy individuals were analyzed for biofilm formation assay.
Statistical analysis
The Wilcoxon sum-of-ranks test was used to analyze the difference between the two 
groups of C. albicans.
Results
Twenty (20) C. albicans isolates from HIV infected patients and 14 C. albicans isolates 
from healthy individuals were studied. Among 34 C. albicans isolates, only one isolate 
showed phenotypic switching (alteration from white to opaque cells) after induction 
on YPD medium. This particular isolate (Cd32) was from an HIV infected patient. The 
yeast cells looked darker and oval compared to the usual C. albicans that is bright and 
spherical in shape after lacto phenol cotton blue staining (Fig. 1). The frequency of the 
phenotypic switching for the Cd32 isolate was 5/4,000 colonies. The variation of the C. 
albicans colony morphology was observed in Ck74 which was isolated from a healthy 
individual. This isolate showed colonies which were not glistening, domed shaped, and 
smooth as usually seen in a normal C. albicans colony morphology. It showed white, vel-
vety and bigger colonies (Fig. 2).
The growth rate of the two series of C. albicans was studied. The cell concentrations 
were measured using a spectrophotometer at 540 nm, and the OD was than deducted 
from the cell concentration. These observations were performed serially on the time 
incubation-based measurements. After 48 h incubation, the growth curves were signifi-
cantly different between the two series (p < 0.001). The C. albicans isolated from HIV 
infected patients grew faster than those isolated from healthy individuals, as shown by 
the higher cell concentration after 48 h incubation. After 48 h incubation, the concen-
tration of C. albicans isolated from HIV infected patients was 8.6 × 106 cells/ml while 
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the concentration of C. albicans isolated from healthy individuals was 7.8 × 106 cells/
ml. After 72 h incubation, the concentration of C. albicans isolated from HIV infected 
patients was 9.5  ×  106 cells/ml while the concentration of C. albicans isolated from 
healthy individuals was 8.2 × 106 cells/ml (Fig. 3).
The ability of the two series of C. albicans to form hyphae was studied by measuring 
the proportion of cells that develop hyphae after incubation in the fetal bovine serum 
at 37 °C for 90 min. The percentages of hyphae forming cells were higher in C. albicans 
collected from HIV infected patients (27.5 %) compared to the healthy individual group 
(14.7 %). However, this trend was not statistically significant (p = 0.1) (Fig. 4).
The hemolytic activity of C. albicans from healthy individuals was significantly higher 
compared to the series from HIV infected patients (p  <  0.001) at both aerobic (6 vs. 
3.5  mm) and anaerobic (3.8 vs. 1.3  mm) conditions. It was noted also that the hemo-
lytic activity of all C. albicans isolates was higher in aerobic (4.5  mm) than anaerobic 
(2.3 mm) conditions in both series of C. albicans (p < 0.05) (Fig. 5).
Fig. 1 Microscopic examination of C. albicans after lacto phenol cotton blue staining. a Cd32 underwent 
white-opaque switching; Opaque cells (arrow) appear oval, dark, and polymorphic. b White cells (arrow) 
appear spherical and bright. The observations were done in ×400 magnification.
Fig. 2 C. albicans colonies on yeast extract peptone dextrose (YPD) agar. a Colony morphology of Ck74, iso-
lated from a healthy individual, has morphological switching. The colonies appear white, velvety and bigger. 
b Representative colonies of other C. albicans isolates appear glistening, domed shaped, and smooth.
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The cut-off points of both biofilm forming and non biofilm forming abilities were 
defined according to the formula: (3StDev  +  mean of the control). The cut off was 
OD =  0.346. The distribution of the biofilm forming characteristic of the C. albicans 
isolates is shown in Table 1. The isolates with OD similar or less than the cut-off were 
considered non adhered or non biofilm forming. The isolates with OD exceeding the 
cut-off were considered as able to adhere (weak, moderate and strong) or biofilm form-
ing. The data were introduced into a 2 × 2 contingency table and the Odds Ratios were 
subsequently computed. The ability of the two series of C. albicans to develop a biofilm 
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Fig. 3 Growth rate of C. albicans. Cells concentration was measured using a spectrophotometer at 540 nm. 
Data were obtained from duplicate measurements for each isolate. After 48 h incubation, the cell concentra-
tion of the C. albicans collected from HIV infected patients were significantly higher than those collected from 



























C. albicans isolates 
Fig. 4 The percentages of hyphae forming cells of C. albicans isolated from HIV infected patients were not 
different from those isolated from healthy individuals (p = 0.1). The data were obtained from duplicate 
independent cell counting.
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the same frequency of developing biofilms compared to those isolated from healthy indi-
viduals (OR = 4.2; 95 % CI 0.724–26.559) (Table 1).
Discussion
Our data showed that phenotypic switching, white-opaque cells and the colony mor-
phology change are not frequently found among C. albicans isolated from HIV infected 
patients and also from healthy individuals. Previous reports showed that there were 
high frequencies of phenotypic switching among C. albicans isolated from HIV infected 
patients (Vargas et al. 2000). The discrepancy may have resulted from the diversity of C. 
albicans circulating in different geographical areas and also from different study meth-
ods. It is well known that phenotypic switching in C. albicans is a complex mechanism 
influenced by environmental conditions such as CO2 concentration, temperature, and 
nutrient availability (Huang et al. 2009; Alby and Bennett 2009). Our data suggests that 
the frequency of phenotypic switching was similar between C. albicans isolated from 
both the HIV infected and healthy individual groups.
The high prevalence of azole resistant C. albicans isolated from an HIV infected 
patient has been documented (Dos Santos Abrantes et  al. 2014). This phenomenon is 
aggravated by the presence of a biofilm which is naturally resistant to antifungal agents. 
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Fig. 5 Hemolytic activity of C. albicans isolated from HIV infected patients were significantly lower than 
isolates obtained from healthy individuals in both aerobic and anaerobic conditions (**) (p < 0.001). The two 
series of C. albicans showed significantly higher hemolytic activities in aerobic conditions (*) (p < 0.05). The 
data were obtained from triplicate independent experiments.
Table 1 The biofilm forming characteristics of C. albicans according to its origin
Origin of C. albicans Non  
biofilm  
forming








HIV infected 5 7 6 2 20
Healthy individual 7 1 3 1 12
Total 12 8 9 3 32
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colonize at the surface of epithelial cells of the oral cavities of patients (King et al. 1980). 
Furthermore, cell density has a role in the phenotypic resistance of a biofilm to anti-
fungals (Perumal et al. 2007). Figure 3 showed that the C. albicans collected from HIV 
infected patients have significantly higher cell growth rate than those isolated from 
healthy individuals. This result suggests that C. albicans isolated from HIV infected 
patients are more virulent compared to isolates taken from healthy individuals.
It should be noted that Cd32, the isolate that showed white-opaque switching, had 
the highest growth rate among all other C. albicans isolates. Meanwhile, the growth 
rate of Ck74 which showed colony morphology switching, is similar with other isolates. 
This is not in accordance to a previously reported study where it was reported that in 
some mutant C. albicans, the cellular growth rate has a negative correlation with white-
opaque switching (Alby and Bennett 2009). However, because of the low frequency of 
white-opaque switching in our experiments, the authors could not further confirm the 
relationship between the two variables.
Candida albicans is able to form pseudohyphae and true hyphae. Hyphae formation is 
considered an important virulence factor that facilitates yeast to become pathogenic in 
humans (Lo et al. 1997; Mayer et al. 2013). The hyphae of C. albicans may have the same 
properties of other fungal hyphae such as, the ability to exert mechanical force, facilitate 
penetration of the epithelial surface, and damage endothelial cells. These are the charac-
teristics of hyphae as a virulence factor (Kumamoto and Vinces 2005). Our data showed 
that the hyphae formation of C. albicans collected from HIV infected patients were not 
different from those of healthy individuals. It is suggested that the C. albicans from HIV 
infected patients are similar with healthy individuals in terms of virulence.
The hemolytic activity of C. albicans is considered a virulence factor that influences 
the pathogenicity of the yeast. Some metals were found to be essential for various cellu-
lar protein and enzyme functions such as iron, zinc, manganese and copper (Mayer et al. 
2013). Candida albicans expresses a hemolytic factor which allows it to acquire iron 
from host erythrocytes. Candida albicans may acquire this iron by producing factors 
which can release hemoglobin by lysing erythrocytes (Manns et  al. 1994). Our results 
showed that all C. albicans isolates have hemolytic activities as previously reported by 
Mane et  al. (2011). The hemolytic activity of C. albicans isolated from HIV infected 
patients was lower compared to the isolates from healthy individuals. It may be sug-
gested that C. albicans from HIV infected patients are less virulent.
Candida albicans remains the fungal species most commonly associated with biofilm 
formation (Ramage et al. 2005). Our results showed that only 42 % of C. albicans isolated 
from healthy individuals were able to form a biofilm (consist: weakly–moderate–strongly 
adhered). In contrast, 75 % of C. albicans from HIV infected patients were biofilm form-
ing isolates (Table 1). However, 2-way contingency table analysis did not confirm that 
C. albicans isolated from HIV infected patients were more virulent (OR  =  4.2; 95  % 
CI 0.724–26.559). The authors prefer to use the cut-off value of OD to describe the bio-
film formation ability among the two groups of C. albicans. Using this approach, the 
authors can evaluate which isolates actually adhered to the polystyrene surface. This 
result is in agreement with a previously published report stating that, biofilm formation 
of C. albicans was not considered different between HIV infected patients and healthy 
individuals (Jin et al. 2003).
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Biofilm formation has an important role in the development of clinically resistant C. 
albicans against antifungal treatment (Kuhn et al. 2002; Mukherjee et al. 2003). Resist-
ance to antifungals may result in higher morbidity and mortality since infections with 
antifungal resistant strains are very difficult to manage in the clinics. Biofilm forma-
tion is influenced by hyphae formation, one of the important phases of biofilm develop-
ment. Two C. albicans mutants showed that the hypha-negative mutant produced only 
the basal layer, and the yeast-negative mutant produced only the outer layer which was 
more easily detached from the catheter. This finding suggests that dimorphism might 
be necessary for biofilm architecture and structure (Kojic and Darouiche 2004). Our 
data showed that C. albicans isolated from HIV infected patients have similar ability to 
develop biofilms compared to those from healthy individuals. This result paralled with 
our data showing similar hyphae formation but not with significantly higher cell growth 
of C. albicans isolated from HIV infected patients.
In conclusion, the role of virulence factors of C. albicans in the opportunistic infec-
tion pathogenesis collectively with the immunocompromised condition of HIV infected 
patients is not yet clearly elucidated. The virulence factors of C. albicans may not be 
working in the same manner to facilitate infection in HIV infected patients and also in 
healthy individuals. It is also recognized that there are various factors regulating the 
pathogenecity of C. albicans.
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